Literature DB >> 30639100

Distinctive Activation Mechanism for Angiotensin Receptor Revealed by a Synthetic Nanobody.

Laura M Wingler1, Conor McMahon2, Dean P Staus1, Robert J Lefkowitz3, Andrew C Kruse4.   

Abstract

The angiotensin II (AngII) type 1 receptor (AT1R) is a critical regulator of cardiovascular and renal function and is an important model for studies of G-protein-coupled receptor (GPCR) signaling. By stabilizing the receptor with a single-domain antibody fragment ("nanobody") discovered using a synthetic yeast-displayed library, we determined the crystal structure of active-state human AT1R bound to an AngII analog with partial agonist activity. The nanobody binds to the receptor's intracellular transducer pocket, stabilizing the large conformational changes characteristic of activated GPCRs. The peptide engages the AT1R through an extensive interface spanning from the receptor core to its extracellular face and N terminus, remodeling the ligand-binding cavity. Remarkably, the mechanism used to propagate conformational changes through the receptor diverges from other GPCRs at several key sites, highlighting the diversity of allosteric mechanisms among GPCRs. Our structure provides insight into how AngII and its analogs stimulate full or biased signaling, respectively.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  G protein-coupled receptor; GPCR; angiotensin receptor; biased agonism; nanobody; single-domain antibody; yeast display

Mesh:

Substances:

Year:  2019        PMID: 30639100      PMCID: PMC6367718          DOI: 10.1016/j.cell.2018.12.006

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  61 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

2.  Quantifying ligand bias at seven-transmembrane receptors.

Authors:  Sudarshan Rajagopal; Seungkirl Ahn; David H Rominger; William Gowen-MacDonald; Christopher M Lam; Scott M Dewire; Jonathan D Violin; Robert J Lefkowitz
Journal:  Mol Pharmacol       Date:  2011-05-24       Impact factor: 4.436

Review 3.  Nanobody-based products as research and diagnostic tools.

Authors:  Thomas De Meyer; Serge Muyldermans; Ann Depicker
Journal:  Trends Biotechnol       Date:  2014-04-01       Impact factor: 19.536

4.  Beta-arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes.

Authors:  Keshava Rajagopal; Erin J Whalen; Jonathan D Violin; Jonathan A Stiber; Paul B Rosenberg; Richard T Premont; Thomas M Coffman; Howard A Rockman; Robert J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-23       Impact factor: 11.205

5.  Characterization of Angiotensin II Molecular Determinants Involved in AT1 Receptor Functional Selectivity.

Authors:  Ivana Domazet; Brian J Holleran; Alexandra Richard; Camille Vandenberghe; Pierre Lavigne; Emanuel Escher; Richard Leduc; Gaétan Guillemette
Journal:  Mol Pharmacol       Date:  2015-03-25       Impact factor: 4.436

6.  Structure of the Angiotensin receptor revealed by serial femtosecond crystallography.

Authors:  Haitao Zhang; Hamiyet Unal; Cornelius Gati; Gye Won Han; Wei Liu; Nadia A Zatsepin; Daniel James; Dingjie Wang; Garrett Nelson; Uwe Weierstall; Michael R Sawaya; Qingping Xu; Marc Messerschmidt; Garth J Williams; Sébastien Boutet; Oleksandr M Yefanov; Thomas A White; Chong Wang; Andrii Ishchenko; Kalyan C Tirupula; Russell Desnoyer; Jesse Coe; Chelsie E Conrad; Petra Fromme; Raymond C Stevens; Vsevolod Katritch; Sadashiva S Karnik; Vadim Cherezov
Journal:  Cell       Date:  2015-04-23       Impact factor: 41.582

7.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

8.  Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2.

Authors:  Huijun Wei; Seungkirl Ahn; Sudha K Shenoy; Sadashiva S Karnik; László Hunyady; Louis M Luttrell; Robert J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-29       Impact factor: 11.205

9.  Sortase ligation enables homogeneous GPCR phosphorylation to reveal diversity in β-arrestin coupling.

Authors:  Dean P Staus; Laura M Wingler; Minjung Choi; Biswaranjan Pani; Aashish Manglik; Andrew C Kruse; Robert J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-26       Impact factor: 11.205

10.  Yeast surface display platform for rapid discovery of conformationally selective nanobodies.

Authors:  Conor McMahon; Alexander S Baier; Roberta Pascolutti; Marcin Wegrecki; Sanduo Zheng; Janice X Ong; Sarah C Erlandson; Daniel Hilger; Søren G F Rasmussen; Aaron M Ring; Aashish Manglik; Andrew C Kruse
Journal:  Nat Struct Mol Biol       Date:  2018-02-12       Impact factor: 15.369

View more
  56 in total

1.  Molecular mechanism of biased signaling in a prototypical G protein-coupled receptor.

Authors:  Carl-Mikael Suomivuori; Naomi R Latorraca; Laura M Wingler; Stephan Eismann; Matthew C King; Alissa L W Kleinhenz; Meredith A Skiba; Dean P Staus; Andrew C Kruse; Robert J Lefkowitz; Ron O Dror
Journal:  Science       Date:  2020-02-21       Impact factor: 47.728

2.  Angiotensin and biased analogs induce structurally distinct active conformations within a GPCR.

Authors:  Laura M Wingler; Meredith A Skiba; Conor McMahon; Dean P Staus; Alissa L W Kleinhenz; Carl-Mikael Suomivuori; Naomi R Latorraca; Ron O Dror; Robert J Lefkowitz; Andrew C Kruse
Journal:  Science       Date:  2020-02-21       Impact factor: 47.728

3.  Genetic code expansion and photocross-linking identify different β-arrestin binding modes to the angiotensin II type 1 receptor.

Authors:  Laurence Gagnon; Yubo Cao; Aaron Cho; Dana Sedki; Thomas Huber; Thomas P Sakmar; Stéphane A Laporte
Journal:  J Biol Chem       Date:  2019-09-17       Impact factor: 5.157

Review 4.  Exploring cellular biochemistry with nanobodies.

Authors:  Ross W Cheloha; Thibault J Harmand; Charlotte Wijne; Thomas U Schwartz; Hidde L Ploegh
Journal:  J Biol Chem       Date:  2020-08-31       Impact factor: 5.157

Review 5.  Harnessing Ion-Binding Sites for GPCR Pharmacology.

Authors:  Barbara Zarzycka; Saheem A Zaidi; Bryan L Roth; Vsevolod Katritch
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

6.  Structure and development of single domain antibodies as modules for therapeutics and diagnostics.

Authors:  Robert J Hoey; Hyeyoung Eom; James R Horn
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-09

Review 7.  A cellular perspective of bias at G protein-coupled receptors.

Authors:  Thomas J Fernandez; Monica De Maria; Braden T Lobingier
Journal:  Protein Sci       Date:  2020-04-27       Impact factor: 6.725

Review 8.  Advances in therapeutic peptides targeting G protein-coupled receptors.

Authors:  Anthony P Davenport; Conor C G Scully; Chris de Graaf; Alastair J H Brown; Janet J Maguire
Journal:  Nat Rev Drug Discov       Date:  2020-03-19       Impact factor: 84.694

9.  Differential Roles of Extracellular Histidine Residues of GPR68 for Proton-Sensing and Allosteric Modulation by Divalent Metal Ions.

Authors:  Xi-Ping Huang; Terrence P Kenakin; Shuo Gu; Brian K Shoichet; Bryan L Roth
Journal:  Biochemistry       Date:  2020-09-10       Impact factor: 3.162

10.  Synthetic nanobodies as angiotensin receptor blockers.

Authors:  Conor McMahon; Dean P Staus; Laura M Wingler; Jialu Wang; Meredith A Skiba; Matthias Elgeti; Wayne L Hubbell; Howard A Rockman; Andrew C Kruse; Robert J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.